Your session is about to expire
← Back to Search
Behavioural Intervention
Virtual Reality Mindfulness for Anxiety
N/A
Waitlist Available
Led By Michelle Pelcovitz
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after first intervention (use of vr) and at hospital discharge an average of 10 days later
Awards & highlights
Study Summary
This trial will assess whether a virtual reality mindfulness program is an acceptable intervention for patients with anxiety, and whether it reduces symptoms of anxiety.
Who is the study for?
This trial is for adults over 18 who are experiencing anxiety or emotional distress and have been recommended by their healthcare team to try a VR mindfulness program. They must be able to agree to participate. People with severe motion sickness, seizures, visual problems, vertigo, cognitive issues like delirium, or a history of psychosis cannot join.Check my eligibility
What is being tested?
The study is testing whether using Virtual Reality (VR) technology can help people feel less anxious by practicing mindfulness skills. Participants will use the VR program as part of their clinical treatment and researchers will see if they find it acceptable and effective in reducing anxiety symptoms.See study design
What are the potential side effects?
There may not be direct side effects from the VR mindfulness program itself; however, individuals prone to motion sickness or those with certain pre-existing conditions might experience discomfort such as nausea or dizziness while using the VR headset.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately before first intervention (use of vr) and at hospital discharge an average of 10 days later
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately before first intervention (use of vr) and at hospital discharge an average of 10 days later
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in composite score on Client Satisfaction Questionnaire-8 (CSQ-8; Attkisson & Zwick, 1982)
Secondary outcome measures
Mean change in General Anxiety Disorder-7 (GAD-7; Spitzer et al., 2006) from baseline to discharge
Mean change in Subject Units of Distress (SUDS) from pre- to post-VR
Mean change in Subjective units of relaxation from pre-to post-VR
Trial Design
1Treatment groups
Experimental Treatment
Group I: Patients using VR Mindfulness ProgramExperimental Treatment1 Intervention
Participants are inpatients on any NYP/WCM unit that use VR mindfulness programs; any patient referred for a psychological or neuropsychological evaluation by their treatment team will have the opportunity to complete the VR program. The study is seeking to evaluate the feasibility and preliminary efficacy of the VR mindfulness intervention.
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,055 Previous Clinical Trials
1,316,266 Total Patients Enrolled
8 Trials studying Anxiety
289 Patients Enrolled for Anxiety
Brain & Behavior Research FoundationOTHER
61 Previous Clinical Trials
2,784 Total Patients Enrolled
2 Trials studying Anxiety
178 Patients Enrolled for Anxiety
Michelle PelcovitzPrincipal InvestigatorWeill Cornell Psychiatry
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have not previously participated in virtual reality mindfulness therapy.The treatment team has recommended using VR mindfulness intervention.You have a history of severe motion sickness, seizures, or psychiatric disorders that may affect your ability to participate in the study. You may also have experienced problems with your vision, balance, or thinking.You have been referred to see a psychologist or neuropsychologist.
Research Study Groups:
This trial has the following groups:- Group 1: Patients using VR Mindfulness Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available opportunities for participants in this research?
"According to clinicaltrials.gov, this medical trial is not currently enrolling new patients; it was initially posted on May 6th 2022 and last edited on July 25th 2022. However, there are 388 other clinical trials that are actively searching for participants at the moment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger